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Accurately and reliably measuring the presence and severity of Obsessive-Compulsive
Disorder (OCD) symptoms is essential for both routine clinical work and research.
The current study investigated psychometric properties of the dimensional
obsessive-compulsive scale-short form (DOCS-SF). DOCS-SF was developed and
validated in Norwegian. DOCS-SF contains a checklist with four symptom categories
and five severity items scored on a zero to eight scale yielding a total score of 0–40. Data
were collected from adults with a current diagnosis of OCD (n = 204) and a community
comparison group (n = 211). The results provided evidence of internal consistency and
convergent validity, although evidence for discriminant validity was mixed. Evidence
was also found for diagnostic sensitivity and specificity, and treatment sensitivity. The
analyses suggested a cut-off score of 16. In summary, the data obtained proved similar
to studies published on the original dimensional obsessive-compulsive scale. There
is strong evidence for the reliability and validity of the DOCS-SF for assessing OCD
symptoms in individuals with this condition and in non-clinical individuals.
Keywords: psychometric properties, obsessive-compulsive disorder, brief questionnaire, evidence-based
assessment, dimensional obsessive-compulsive scale short-form
INTRODUCTION
Obsessive-compulsive disorder (OCD) is a heterogeneous condition, and factor-analytic research
has consistently found clusters of symptoms along 3–5 dimensions (Mataix-Cols et al., 2005,
2016). As a consequence of the need for a self-report measure that incorporates different symptom
dimensions, Abramowitz et al. (2010) developed the 20-item Dimensional Obsessive-Compulsive
Scale (DOCS).The DOCS assesses the severity of the four most consistently replicated O-C
symptom dimensions: (a) contamination/washing, (b) harm obsessions/checking compulsions, (c)
symmetry/ordering, and (d) unacceptable thoughts. Hoarding, which is no longer considered a
presentation of OCD, is not assessed. TheDOCS provides an index of severity that is independent of
Abbreviations: OCD, Obsessive-compulsive disorder; DOCS, Dimensional Obsessive-Compulsive Scale; DOCS-SF,
Dimensional Obsessive Compulsive Scale-Short Form; OCI-R, Obsessive-Compulsive Inventory-Revised; Y-BOCS, Yale-
Brown Obsessive-Compulsive Scale; GAD-7, Generalized Anxiety Disorder, 7-items; PHQ-9, Patient Health Questionnaire,
9-items; ROC, Receiver Operating Characteristics; CSSRI, Socio-Demographic and Service Receipt Inventory; AUC, Area
Under the Curve.
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the number and types of obsessions and compulsions present,
and consequently does not confound the number of different
types of obsessions and compulsions with severity. Rather, the
DOCS measures symptom severity as a function of empirically
supported parameters for each of the four dimensions: (a)
time occupied by obsessions and compulsions, (b) avoidance,
(c) associated distress, (d) interference with function, and (e)
refraining from compulsions. Each item is rated on a 0–4 scale,
yielding a total score from 0 to 80 as well as individual subscale
scores ranging from 0 to 20.
Numerous studies have been conducted evaluating the
psychometric properties of the DOCS in clinical and non-clinical
samples and in various languages (Abramowitz et al., 2010;
Enander et al., 2012; Wang et al., 2012; Kim et al., 2013; Ólafsson
et al., 2013; López-Solà et al., 2014; Melli et al., 2015). The
mean total scores among OCD samples have ranged from 25.3
to 32.7 with standard deviations ranging from 14.0 to 19.8.
For students/comparison group the mean scores have ranged
from 10.8 to 13.1 with standard deviations ranging from 8.8 to
10.2. Cronbach’s alpha values have ranged from 0.87 to 0.95 for
the total DOCS score. Two studies have examined test-retest
reliability (Abramowitz et al., 2010; López-Solà et al., 2014),
finding rs of 0.66 and 0.81 for OCD samples, and 0.43 for a
student sample. Correlations with the Yale-Brown Obsessive-
Compulsive Scale (Y-BOCS; Goodman et al., 1989) interview,
which provides a global measure of severity, ranged from 0.47 to
0.64, and correlations with the self-report Obsessive-Compulsive
Inventory-Revised (OCI-R; Foa et al., 2002) ranged from 0.69
to 0.86. The DOCS also appears sensitive to treatment effects,
and Abramowitz et al. (2010) found that a cut-off score of
21 optimally differentiated between individuals diagnosed with
OCD and those with other anxiety disorders with 70% sensitivity
and 70% specificity; and a cut-off of 18 optimally differentiated
OCD patients from comparison group with 78% sensitivity and
78% specificity. López-Solà et al. (2014) found a cut-off of 15
being optimal, giving 71% sensitivity and 76% specificity against
non-clinical comparison group. Taken together, these findings
provide strong evidence for the DOCS as a reliable and valid
measure of the severity of obsessive-compulsive symptoms in
clinical and non-clinical samples.
Although, the DOCS represents an improvement over
previously developed self-report measures, clinicians and
researchers are constantly seeking more efficient measures that
still provide a reliable and valid measurement of the presence
and severity of OCD symptoms. Accordingly, we undertook the
present study to develop the Dimensional Obsessive Compulsive
Scale-Short Form (DOCS-SF) and to evaluate its psychometric
characteristics.
The DOCS-SF is a 5-item self-report questionnaire developed
on the basis of and inspired by the original DOCS, as well as
Y-BOCS. DOCS-SF was developed and validated in Norwegian.
So far no English version of DOCS-SF has been developed and
tested. Lifetime prevalence of OCD in Norway is 1.6%, and
higher for women than men (Kringlen et al., 2001). A major
difference between DOCS-SF and the original DOCS is that the
former uses a checklist replacing the different sub-scales of the
DOCS. Respondents indicate on a checklist if they experience
any of the unpleasant and intrusive thoughts (obsessions) that
are characteristic of the four symptom dimensions assessed
by the original DOCS. There is a definition for each of the
symptom dimension listed on the questionnaires. This is different
from the multiple examples for each dimension in the original
DOCS. A fifth option “other intrusive and unpleasant thoughts”
is also available. Here, respondents can specify any obsessive-
compulsive symptoms they experience that do not fit with
the four symptom dimensions. A benefit of this is shorter
administration time. As a result DOCS-SF might be used as
a brief screening tool and for session-to-session ratings. On
the other hand, the DOCS-SF does not provide estimates of
symptom scores for the various obsessive-compulsive symptom
dimensions. This could be confusing to individuals and might
lead to less exact or valid responses. This is particularly relevant
for the “other” category of the DOCS-SF checklist. For example,
a patient might include depressive or other anxiety symptoms
within this category, and consider these non-OCD symptoms
when responding to the five severity items. In the second part
of the DOCS-SF, respondents rate the severity (during the past
week) of the obsessions and compulsions they endorsed on the
checklist. Severity is rated along the five parameters similar
to those used in the original DOCS. This as evidence of the
reliability and validity of these parameters has been previously
reported. The DOCS-SF items, however, are rated from 0 to 8 (as
opposed to 0–4 on the original DOCS). The change from 0–4 to
0–8 Likert scale was done in order to yield a range of severity sum
scores similar to the range found in the Y-BOCS.
If its psychometric properties are sound, the DOCS-SF
might provide general practitioners’ (GP) with a brief initial
screening for OCD symptoms before GPs refer them to specialist
assessment and treatment, improve planning and evaluation
of treatment effects among specialist health care providers,
and give researchers a new valid and time-efficient measure
of OCD symptom severity. We hypothesized that the DOCS-
SF would show evidence of good internal consistency and
convergence with other measures of OCD symptoms (i.e., the
Y-BOCS interview, Y-BOCS self-report, and OCI-R). We also
predicted that we would find evidence of discriminant validity
as evident by weaker correlations with measures of depression
and anxiety. We further expected that the DOCS-SF would be
sensitive to treatment and that scores on the DOCS-SF would be
higher for patients with OCD than for non-clinical comparison
group. Finally, we sought to provide cut-off scores with optimal
sensitivity and specificity for distinguishing patients with OCD
from non-clinical comparison group.
METHODS
Participants and Procedure
The total sample included 415 adults in two groups: 204 patients
diagnosed with OCD, and 211 unselected adults (the comparison
group). The study selected and used data from a medical
quality registry for the patient sample. Eligible patients were
as follows: Patients must first be referred from their GP to
specialist health care in Norway. If the specialist health care
suspects OCD, they then refer the patients to an outpatient OCD
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clinic. All referred patients are offered to take part in a standard
quality assurance procedure. The procedure includes patients
filling out several questionnaires prior to their assessment
session. The assessment session consist of a structured diagnostic
assessment usingMINI International Neuropsychiatric Interview
(Sheehan et al., 1997, 1998) and the Y-BOCS interview (by
trained clinical psychologists or psychiatrists). Any patients who
underwent the assessment and completed the Patient Health
Questionnaire (PHQ-9; Spitzer et al., 1999), Generalized Anxiety
Disorder questionnaire (GAD-7; Spitzer et al., 2006), Obsessive
Compulsive Inventory-Revised (OCI-R; Foa et al., 2002), DOCS-
SF, and the Client Socio-Demographic and Service Receipt
Inventory (CSSRI; Chisholm et al., 2000) (all measures are
described further below) were used for this sample. All patients
without a primary diagnosis of OCD were not drawn for
the current sample, but otherwise no exclusion criteria were
used. Table 1 summarizes the demographic characteristics of
both groups. The average age of OCD patients was 31.0 years
(SD = 10.5). About two-thirds (70.6%) of the patients were
females, and about one-third (37.3%) of the patients presented
with a comorbid disorder. The most prevalent comorbidity was
depression (16.7%) and generalized anxiety disorder (10.3%).
The medical quality registry was approved by the local Data
Protection Official for Research (Personvernombudet). Full
ethical review and approval was not required in accordance with
the national and institutional guidelines.
The comparison group (ageM = 31.2 ± 11.5, 71.6% females)
was recruited through social media and mailing lists for students,
asking volunteers to complete an online survey containing the
TABLE 1 | Demographic Characteristics for the OCD and comparison group.
Group
OCD Comparison group
Sex, % females 70.6% 71.6%
AGE
M (SD) 31.0 (10.5) 31.2 (11.5)
Range 18–69 18–74
HIGHEST ATTAINED EDUCATION*
Elementary school 8.9%
High school/Vocational high school 48.2%
3-Year college degree or more 42.9%
WORK STATUS
Working 37.6% 44.5%
Students 29.2% 46.4%
Disability benefits/work assessment allowance 17.4% 3.3%
Other forms of income 15.7% 5.7%
Marital status (% unmarried) 54.4% 47.1%
Comorbid disorders** 37.3%
Depression 16.7%
Generalized anxiety disorder 10.3%
*The comparison group did not report highest attained education and was not assessed
for psychiatric diagnoses.
**The two most common comorbid diagnoses was depression and generalized anxiety
disorder.
following: Demographic questionnaire, DOCS-SF, OCI-R, GAD-
7, PHQ-9, and finally Y-BOCS-SR. Use of online collection
methods conserves resources and previous research has found
online methods to have equivalent psychometric properties as
paper-and-pencil methods (Holländare et al., 2010). Participants
received no compensation for completing the survey. There were
no significant differences in age, t(413) = 0.16, p = 0.26, and sex
[X2(1) =0.48, p =0.83], between OCD patients and comparison
group. A smaller proportion of the comparison group was single
compared to the OCD patients [X2(1) = 5.41, p =0.20]. More
patients than comparison group participants were on disability
benefits/work assessment allowance or other forms of income
[X2(3) = 37.66, p < 0.001]. Also, applying the cut-off criteria for
Y-BOCS 93% of the comparison group were classified correctly
as non-clinical.
A subsample of 88 OCD participants received treatment
consisting of exposure and response prevention (EX/RP) either in
a concentrated 4-day format (Concentrated Exposure Treatment;
Havnen et al., 2013) or in an ordinary outpatient setting with
weekly sessions. The concentrated treatment mixed individual
exposure therapy and group therapy and the patient to therapist
ratio was 1:1. Day 1 (4 h) included psychoeducation and exposure
planning; days 2 and 3 (∼8 h each) were used for therapist
assisted exposure; during day 4 the focus was on lessons
learned and planning self-exposures for the next 3 weeks.
Three months after completing treatment patients were offered
an individual follow-up session. An independent assessor not
otherwise involved in the patient’s treatment conducted Y-BOCS
interviews post-treatment. The individual treatment followed the
same principles of exposure-based treatment delivered over 90
min sessions, with 16 sessions per patient. Clinical psychologists
or psychiatrists with training in the use of exposure treatment
delivered the treatment. A majority (80.5%) of the subsample
completed the 4-day format.
Measures
The following questionnaires were used in the study.
DOCS-SF
As described previously, the DOCS-SF is a brief (5-item) self-
report measure derived from the original 20-item DOCS. Total
scores range from 0 to 40. A test of readability was applied
(Using the LIX formula). This gave a readability index score
of 41 corresponding to average readability (comparable to a
regular newspaper text). The type/token ratio was 51.5%, the
word variation index was 48, and the word variation ratio was
87.8%. See Appendix A1 in Supplementary Material for a copy of
the questionnaire.
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS;
Goodman et al., 1989)
The Y-BOCS is the most widely used tool for assessing the
global severity of OCD. It contains two parts: a checklist
of over 50 types of obsessions and compulsions, and a 10-
item severity scale on which the most prominent obsessions
and compulsions are rated. Items on the severity scale (rated
from 0 to 4) assess the following parameters of obsessions
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(items 1–5) and compulsions (items 6–10): time, interference,
distress, resistance, and control. Total scores range from
0 to 40. There is good evidence for the Y-BOCS’s inter-
rater reliability, test-retest reliability, and moderate to strong
evidence of internal consistency (Goodman et al., 1989). A
validation study of the Norwegian Y-BOCS showed evidence
of good reliability and validity (Eilertsen et al., Unpublished
manuscript).
The OCD group was administered the Y-BOCS by a trained
clinician whereas the comparison group completed the self-
report version (Y-BOCS-SR), which has shown to have good
reliability and convergent validity (Grabill et al., 2008). One study
has reported a correlation between Y-BOCS-SR and Y-BOCS total
score of 0.79 in a clinical sample (Steketee et al., 1996). Cronbach’s
alpha was 0.92.
Obsessive-Compulsive Inventory-Revised (OCI-R;
Foa et al., 2002)
The OCI-R is an 18-item self-report tool measuring six different
symptom dimensions of OCD: Washing, obsessing, hoarding,
checking, ordering, and neutralizing symptoms. Participants rate
the symptoms on a scale from 0 (“Not at all”) to 3 (“Extremely”).
Total scores range from 0 to 72. Evidence supports its good
psychometric properties, both in the original (Foa et al., 2002),
and in the translated Norwegian version (Solem et al., 2010). In
the current sample, the OCI-R showed adequate psychometric
properties with a Cronbach’s alpha of 0.83.
Patient Health Questionnaire, 9-items (PHQ-9; Spitzer
et al., 1999)
The PHQ-9 is a 9-item self-report tool, based on the nine criteria
for diagnosing depression in DSM-IV. The patient scores the
frequency of symptoms on a scale from zero (“Not at all”)
to three (“Nearly every day”). Total scores range from 0 to
27. Evidence supports the PHQ-9 as a valid instrument for
measuring depression with good test-retest reliability (Hansson
et al., 2009). The PHQ-9 was translated into Norwegian by
Pfizer. To our knowledge no study has specifically examined the
psychometric properties of PHQ-9. Even so, several studies have
used the Norwegian PHQ-9 with adequate results (Solem et al.,
2015; Smith et al., 2017). This also applies for the GAD-7. In
the current sample, the PHQ-9 showed adequate psychometric
properties with a Cronbach’s alpha of 0.85.
Generalized Anxiety Disorder, 7-items (GAD-7;
Spitzer et al., 2006)
The GAD-7 is a brief 7-item self-report tool developed on criteria
for diagnosing generalized anxiety disorder in DSM-IV. The
patient scores the frequency of symptoms from 0 (“Not at all”)
to three (“Nearly every day”). Total score ranges from 0 to 21.
Evidence suggests good psychometric properties (Spitzer et al.,
2006; Swinson, 2006). The GAD-7 was translated into Norwegian
by Pfizer. As with PHQ-9, no study has been conducted on the
psychometric properties of GAD-7, but studies have also used
GAD-7 with adequate results (Solem et al., 2015; Smith et al.,
2017). In the current sample, the GAD-7 had a Cronbach’s alpha
of 0.88.
Data Analysis
Our data analytic approach for assessing the psychometric
properties of the DOCS-SF was as follows: First, we compared
the OCD and comparison group on the DOCS-SF and other
study measures. Independent samples t-tests were conducted to
compare the groups along the total scores in order to detect the
ability of the instruments to discriminate between the OCD and
the comparison group. Evidence for validity was then gathered
using (a) Pearson correlation coefficients between scores on the
DOCS-SF and other measures of OCD (convergent validity;
e.g., the OCI-R), and (b) correlations between DOCS-SF and
measures of other constructs (discriminant validity; i.e., PHQ-9
and GAD-7). Evidence of differences between correlations were
assessed using Fisher r-to-z transformation. Treatment sensitivity
was assessed by paired sample t-tests of pre- and post-treatment
values for a sub-sample of the OCD group. Finally, ROC analysis
was used to assess the diagnostic accuracy of the DOCS-SF.
The ROC is a graph of the association between sensitivity (the
degree to which the instrument positively identifies participants
with an actual diagnosis) and 1-specificity (the degree to
which the instrument correctly identifies participants without
a diagnosis as “negative”), and the area under the ROC curve
(AUC) represents how well the instrument performs as a tool
discriminating between clinical and a comparison group. An
AUC-value of 0.5 indicates that the instrument does not perform
better than chance when distinguishing OCD patients from the
comparison group. An optimal cut-off point when choosing
between sensitivity and specificity can be achieved by calculating
the Youden Index (also known as Youden’s J), as suggested by
Perkins and Schisterman (2006). All analyses were conducted
using IBM SPSS Statistics 24.
RESULTS
Group Comparisons
Table 2 displays mean scores on the DOCS-SF, Y-BOCS, OCI-
R, and PHQ-9 for the OCD and comparison group. Between-
group t-tests (also shown in Table 2) revealed that the OCD
sample had significantly higher scores on all measures, including
the DOCS-SF, when compared to the comparison group. The
far right column of the table presents effect sizes (Cohen’s d)
for the group comparisons. Using (Cohen, 1988) criteria for
interpretation, large effects were observed on all study measures.
Y-BOCS and DOCS-SF yielded larger effect sizes compared to the
OCI-R, PHQ-9, and GAD-7.
Table 3 shows the frequency of endorsement of different types
of symptom dimensions on the DOCS-SF checklist, as well as chi-
square tests of the differences. Relative to the non-clinical group,
the OCD group evidenced a significantly greater frequency of
all OCD symptom dimensions (as assessed by the DOCS-SF
checklist) except for symmetry and “other” symptoms.
Reliability
A summary of the Cronbach’s alpha values and inter-item
correlations is displayed in Table 4. As can be seen, these values
provide evidence of good to excellent reliability of the DOCS-SF
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TABLE 2 | Mean scores on study measures for OCD and comparison group.
Measure OCD (N = 244) Comparison group
(N = 211)
t d
M (range) SD M (range) SD
DOCS-SF 26.60 12–40 6.14 4.58 0–31 6.42 35.71* 3.51
Y-BOCS 25.69 16–38 4.77 5.31 0–27 6.05 36.17* 3.77
OCI-R 27.55 5–68 12.34 8.35 0–43 7.80 17.26* 1.91
PHQ-9 12.72 1–26 5.66 5.67 0–27 5.37 11.53* 1.28
GAD-7 12.28 0–21 5.13 4.94 0–21 4.59 13.72* 1.51
*p < 0.0001 (two-tailed), OCD > Comparison group.
OCI-R, Obsessive-Compulsive Inventory-Revised; GAD-7, Generalized Anxiety Disorder;
PHQ-9, Patient Health Questionnaire; Y-BOCS, Yale-BrownObsessive-Compulsive Scale;
DOCS-SF, Dimensional Obsessive Compulsive Scale Short-Form.
TABLE 3 | Percent of participants endorsing different symptom dimensions on the
DOCS-SF checklist.
OCD group Comparison group
DOCS-SF Dimensions Percent (%) Percent (%) X2
Contamination 38.7 10.4 45.11*
Responsibility 34.8 10.4 35.45*
Unacceptable thoughts 24.5 10.0 15.50*
Symmetry/ordering 29.9 24.6 1.45
Other 26.5 25.5 0.05
*p< 0.0001 (two-tailed), OCD>Comparison group. At the checklist patients can endorse
more than one symptom. Consequently the total percentage exceeds 100.
TABLE 4 | Reliability estimates for DOCS-SF.
n α
Total study sample 415 0.94
Comparison group 211 0.91
OCD SAMPLE
Before treatment 204 0.76
After treatmenta 102 0.90
3 months F-UP 67 0.95
6 months F-UP 56 0.94
F-UP, Follow-up.
aFor the group setting, after treatment assessment was conducted 1 week after the 4 days
of intensive treatment, and for the individual therapy this is 1 week after the last session
of their therapy (i.e., before the 3 months follow-up session). 3 and 6 months follow-up
follow the same time course.
in both samples, and at post-treatment and follow-up among the
treated OCD patients.
Convergent and Discriminant Validity
Evidence
Table 5 presents correlations between scores on the DOCS-SF
and the other study measures. As can be seen, in the comparison
group, and to some extent in the sample as a whole, DOCS-
SF scores were more strongly correlated with other measures
TABLE 5 | Correlations between scores on the DOCS-SF and measures of OCD
symptoms and other constructs.
Measure Group
Total sample OCD patients Comparison group
Y-BOCS 0.92 0.50 0.79
OCI-R 0.79 0.45 0.71
PHQ-9 0.71 0.55 0.61
GAD-7 0.76 0.55 0.64
All correlations significant at p < 0.01 (two-tailed).
OCI-R, Obsessive-Compulsive Inventory-Revised; GAD-7, Generalized Anxiety Disorder;
PHQ-9, Patient Health Questionnaire; Y-BOCS, Yale-BrownObsessive-Compulsive Scale;
DOCS-SF, Dimensional Obsessive Compulsive Scale Short-Form.
of OCD than with measures of other constructs. In the OCD
group, however, the DOCS-SF showed moderate to strong
correlations with measures of OCD as well as with measures
of anxiety and depression. Formal tests of differences between
correlations (Fisher r-to-z transformation) were also conducted,
and supported these findings. The fisher r-to-z transformations
can be found in Appendix (Table B1, Supplementary Material).
In the OCD sample none of the relations reached significance for
differences. In the total sample the relations between DOCS-SF
and Y-BOCSwas stronger than any other relations.While DOCS-
SF and OCI-R was stronger than DOCS-SF and PHQ-9, but not
DOCS-SF and GAD-7.
Treatment Sensitivity
A sub-sample of the OCD patients (n = 88) completed
treatment as described in Participants and Procedures. All
patients completed symptom measures at 1 week following
treatment (post-treatment), and an independent rater conducted
the Y-BOCS interview over the telephone. Table 6 summarizes
the treatment results. The DOCS-SF was sensitive to the effects
of treatment as evidenced by the large effect sizes that were
comparable to those observed on the other measures of OCD
symptoms (i.e., the Y-BOCS and OCI-R).
Receiving Operating Characteristics
We computed the AUC for the DOCS-SF and for the OCI-R (the
only other self-report measure of OCD symptoms in the present
study) as a comparison as shown in Figure 1. We found that the
AUC for the DOCS-SF was 0.98 [95% CI 0.97–0.99], suggesting
that the test discriminated extremely well between patients
diagnosed with OCD and the comparison group. We compared
the AUC between the DOCS-SF and that of the OCI-R, which
was 0.92 (95% CI 0.89–0.95), and found a significant difference
(p < 0.0001). Thus, the DOCS-SF performed significantly better
relative to the OCI-R.
Based on the Youden Index the analysis suggested a cut-off
score of 16. This score had a sensitivity of 96% [95% CI 92–98]
and a specificity of 94% [95% CI 89–96], indicating a good ability
to correctly identify those in the OCD group from those in the
comparison group.
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TABLE 6 | Comparison of pre- and post-treatment scores for patients with
obsessive-compulsive disorder who completed exposure and response
prevention treatment (n = 88).
Measure Pre-treatment Post-treatment d†
M SD M SD
Y-BOCS 25.53 4.65 10.07 4.81 2.44*
DOCS-SF 26.31 5.77 12.43 8.25 1.67*
OCI-R 25.81 11.66 10.68 8.45 1.47*
*p < 0.0001 (two-tailed), Pre-treatment > Post-treatment.
†
Cohen’s d was calculated using average of pre and post-treatment standard deviation,
and corrected for dependence betweenmeans. OCI-R, Obsessive-Compulsive Inventory-
Revised; G; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; DOCS-SF, Dimensional
Obsessive Compulsive Scale Short-Form.
FIGURE 1 | Receiver operating characteristic curves for DOCS-SF and OCI-R.
DISCUSSION
The current study examined the psychometric properties of a
Norwegian short version of the original DOCS. Based on a scale
that assesses the severity of these four best-supported symptom
dimensions, the main objective behind the design of the DOCS-
SF was to create a measure that could provide a brief (5-item)
measure of OCD symptom severity to aid carrying out rapid
screening of OCD or making repeated assessments. Overall, our
findings suggest a psychometrically sound and stable instrument.
First, the DOCS-SF was able to distinguish between OCD
patients and the comparison group, providing evidence of
criterion validity. It is noteworthy that on the DOCS-SF
symptom checklist, there were between-group differences in the
frequency of endorsement of contamination, responsibility, and
unacceptable thoughts symptoms, but no differences between
patients and comparison group on the Symmetry/Ordering
and Other symptom dimensions. Perhaps this reflects the high
prevalence of symmetry and ordering symptoms among non-
clinical samples (e.g., Abramowitz et al., 2014). With regards to
the “Other” category, it is possible that both groups endorsed this
category on the basis of non-OCD symptoms (e.g., depressive or
other anxiety symptoms). The lack of examples in the DOCS-SF
to guide the endorsement of these categories might explain the
relatively weak evidence for discriminative validity as discussed
further below.
Despite the fact that DOCS-SF contains only five items, we
found adequate support for internal consistency, indicating that
the five items measure the same general construct. This was
not surprising given evidence that similar parameters of OCD
symptom severity were found to be reliable and valid indices of
severity on the original DOCS.
Scores on the DOCS-SF also correlated with other self-
report (OCI-R and Y-BOCS) and clinician-interview (Y-BOCS)
measures of OCD, providing strong evidence of convergent
validity for assessing such phenomena. At the same time, scores
on the DOCS-SF correlated strongly with both PHQ-9 and GAD-
7, with more disparity for the comparison group compared
to the OCD sample. Test for the difference of correlations
provided further evidence of this. This suggests mixed evidence
for discriminant validity, which might be especially lacking
among individuals with a clinical diagnosis of OCD. Perhaps
the comorbid conditions within members of the OCD group
accounted for this, as well as a restriction of range in OCD
symptoms at pre-treatment (all participants had moderate to
severe OCD symptoms).
The DOCS-SF was sensitive to treatment effects as indicated
by a pre-post treatment effect size of 1.67. Furthermore, the
analysis of receiver operating characteristics provided strong
evidence for the diagnostic ability of DOCS-SF. A suggested cut-
off score of 16 of the DOCS-SF provided the best combination of
sensitivity and specificity for identifying OCD patients from non-
patients. This is the same cut-off score as used for the Y-BOCS.
Applying the cut-off score 64% of patients were considered non-
clinical post-treatment using the DOCS-SF. The similar score
for OCI-R were 63% (Cut-off of 12; Wootton et al., 2015).
Using empirically derived criteria for Y-BOCS 76% had “mild
symptoms” (0–13; Storch et al., 2015). In summary, these findings
should support the use of DOCS-SF as a tool for measuring
changes between sessions, and GPs could use it as a quick
screening tool for OCD symptoms before they refer patients to
specialist health care.
The present study has a number of limitations that should be
considered alongside our findings. First, we used convenience
sampling to recruit the comparison group, and the samples
were recruited using different methods, which could introduce
a selection bias. While there were no differences in sex and
age between the two samples, the comparison group is not
necessarily representative of the general population. Still, the
mean score for the comparison group on OCI-R is similar to
the number found for the comparison group in the Norwegian
validation of the questionnaire (M = 8.35 ± 7.80 vs. M = 10.44
± 9.18; Solem et al., 2010). Second, the lack of a psychiatric
comparison group to test whether our findings for the OCD
group were specific to this particular disorder is a limitation.
A third shortcoming is the lack of test-retest reliability. Fourth,
comparison group participants were not face-to-face assessed for
psychological disorders and therefore it cannot be excluded that
they satisfied diagnostic criteria. Fifth, the measures used to test
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convergent and discriminant validity have not yet been properly
validated intoNorwegian. Finally, the comparison group used the
self-report Y-BOCS rather than the Y-BOCS interview, which was
used to assess the OCD group.
There are some unanswered questions concerning DOCS-SF.
We recommend future studies to use diagnostic interviews for
the comparison group population as well, thus strengthening the
ROC analysis. More research is needed to explore the possible
weak support for discriminant validity of the DOCS-SF in OCD
samples as this may be a result of comorbidity and restriction
of range. In conclusion, results from the current study should
warrant further clinical use and research on this brief self-report
tool for OCD symptoms.
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